$CREX
CREATIVE REALITIES, INC. Stock $crex

$crex Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000143774924015814 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$13.12M	$12.29M
YoY Change	42.62%	23.54%
Cost Of Revenue	$6.327M	$6.521M
YoY Change	29.18%	34.32%
Gross Profit	$6.788M	$5.764M
YoY Change	57.93%	13.26%
Gross Profit Margin	51.76%	46.92%
Selling, General & Admin	$6.196M	$4.493M
YoY Change	62.03%	11.38%
% of Gross Profit	91.28%	77.95%
Research & Development		$508.0K
YoY Change		38.8%
% of Gross Profit		8.81%
Depreciation & Amortization	$930.0K	$839.0K
YoY Change	16.69%	7.7%
% of Gross Profit	13.7%	14.56%
Operating Expenses	$6.196M	$5.840M
YoY Change	23.97%	12.76%
Operating Profit	$592.0K	-$76.00K
YoY Change	-184.57%	-15.56%
Interest Expense	-$105.0K	$663.0K
YoY Change	-113.34%	-17.43%
% of Operating Profit	-17.74%
Other Income/Expense, Net	-$1.182M	-$24.00K
YoY Change	73.82%	-97.23%
Pretax Income	-$590.0K	-$100.0K
YoY Change	-57.25%	-89.55%
Income Tax	$25.00K	$9.000K
% Of Pretax Income
Net Earnings	-$615.0K	-$109.0K
YoY Change	-56.84%	-89.1%
Net Earnings / Revenue	-4.69%	-0.89%
Basic Earnings Per Share	-$0.06	-$0.01
Diluted Earnings Per Share	-$0.06	-$0.01
COMMON SHARES
Basic Shares Outstanding	10.45M	10.45M
Diluted Shares Outstanding	10.45M	10.42M

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.086M	$2.899M
YoY Change	25.18%	-25.76%
Cash & Equivalents	$4.086M	$2.899M
Short-Term Investments
Other Short-Term Assets	$964.0K	$837.0K
YoY Change	22.96%	4.1%
Inventory	$2.995M	$3.065M
Prepaid Expenses
Receivables	$9.491M	$9.516M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$17.54M	$16.32M
YoY Change	49.98%	25.16%
LONG-TERM ASSETS
Property, Plant & Equipment	$418.0K	$464.0K
YoY Change	-7.73%	89.39%
Goodwill	$26.45M	$26.45M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$393.0K	$112.0K
YoY Change	793.18%	154.55%
Total Long-Term Assets	$52.02M	$51.89M
YoY Change	-0.43%	-0.34%
TOTAL ASSETS
Total Short-Term Assets	$17.54M	$16.32M
Total Long-Term Assets	$52.02M	$51.89M
Total Assets	$69.55M	$68.21M
YoY Change	8.79%	4.77%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.205M	$4.788M
YoY Change	79.98%	55.1%
Accrued Expenses	$4.345M	$3.955M
YoY Change	35.06%	6.15%
Deferred Revenue	$2.946M	$1.777M
YoY Change	4.21%	-50.71%
Short-Term Debt	$10.20M	$10.60M
YoY Change
Long-Term Debt Due	$0.00	$12.77M
YoY Change	-100.0%	158.29%
Total Short-Term Liabilities	$26.73M	$38.74M
YoY Change	50.46%	129.76%
LONG-TERM LIABILITIES
Long-Term Debt	$13.55M	$0.00
YoY Change	16.96%	-100.0%
Other Long-Term Liabilities	$187.0K	$178.0K
YoY Change	37.5%	122.5%
Total Long-Term Liabilities	$13.74M	$178.0K
YoY Change	17.2%	-98.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$26.73M	$38.74M
Total Long-Term Liabilities	$13.74M	$178.0K
Total Liabilities	$41.32M	$39.36M
YoY Change	3.1%	-1.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$54.07M	-$53.46M
YoY Change	2.34%	3.98%
Common Stock	$104.0K	$104.0K
YoY Change	40.54%	40.54%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$28.24M	$28.85M
YoY Change
Total Liabilities & Shareholders Equity	$69.55M	$68.21M
YoY Change	8.79%	4.77%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	-$615.0K	-$109.0K
YoY Change	-56.84%	-89.1%
Depreciation, Depletion And Amortization	$930.0K	$839.0K
YoY Change	16.69%	7.7%
Cash From Operating Activities	$2.268M	$1.938M
YoY Change	-8.4%	-49.9%
INVESTING ACTIVITIES
Capital Expenditures	$665.0K	$6.000K
YoY Change	-43.11%	-80.65%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$665.0K	-$830.0K
YoY Change	-43.11%	-19.73%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-416.0K	-$1.119M
YoY Change	-78.64%	99.11%
NET CHANGE
Cash From Operating Activities	2.268M	$1.938M
Cash From Investing Activities	-665.0K	-$830.0K
Cash From Financing Activities	-416.0K	-$1.119M
Net Change In Cash	1.187M	-$11.00K
YoY Change	-285.18%	-100.48%
FREE CASH FLOW
Cash From Operating Activities	$2.268M	$1.938M
Capital Expenditures	$665.0K	$6.000K
Free Cash Flow	$1.603M	$1.932M
YoY Change	22.65%	-49.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	dei	Amendment Flag AmendmentFlag	false
CY2024Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2024Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666000
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10447000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10447000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10409000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10409000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4587002
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	dei	Document Type DocumentType	10-Q
CY2024Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q1	dei	Document Period End Date DocumentPeriodEndDate	2024-03-31
CY2024Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q1	dei	Entity File Number EntityFileNumber	001-33169
CY2024Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	MN
CY2024Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	41-1967918
CY2024Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	13100 Magisterial Drive, Suite 100
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Louisville
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	KY
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	40223
CY2024Q1	dei	City Area Code CityAreaCode	502
CY2024Q1	dei	Local Phone Number LocalPhoneNumber	791-8800
CY2024Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2024Q1	dei	Trading Symbol TradingSymbol	CREX
CY2024Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10446659
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2899000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2910000	usd
CY2024Q1	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	9516000	usd
CY2023Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	12468000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	3065000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2567000	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	837000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	665000	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	16317000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	18610000	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	464000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	499000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	26453000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	26453000	usd
CY2024Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	23985000	usd
CY2023Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	24062000	usd
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	875000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1041000	usd
CY2024Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	112000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	112000	usd
CY2024Q1	us-gaap	Assets Assets	68206000	usd
CY2023Q4	us-gaap	Assets Assets	70777000	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4788000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7876000	usd
CY2024Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3955000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	3761000	usd
CY2024Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1777000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1132000	usd
CY2024Q1	crex	Customer Deposit Current CustomerDepositCurrent	4411000	usd
CY2023Q4	crex	Customer Deposit Current CustomerDepositCurrent	3233000	usd
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	431000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	505000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	10603000	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	38735000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	20197000	usd
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	444000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	536000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	0	usd
CY2023Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	11208000	usd
CY2024Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	178000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	176000	usd
CY2024Q1	us-gaap	Liabilities Liabilities	39357000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	41946000	usd
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	104000	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	104000	usd
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	82200000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	82073000	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53455000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53346000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	28849000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	28831000	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	68206000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	70777000	usd
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12285000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9944000	usd
CY2024Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6521000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4855000	usd
CY2024Q1	us-gaap	Gross Profit GrossProfit	5764000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	5089000	usd
CY2024Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1465000	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1136000	usd
CY2024Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	508000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	366000	usd
CY2024Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3028000	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2898000	usd
CY2024Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	839000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	779000	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	5840000	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	5179000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-76000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-90000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	663000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	803000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-604000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	76000	usd
CY2024Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	35000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12000	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-867000	usd
CY2024Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-100000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-957000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-109000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1000000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10421000
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7351000
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	10421000
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7351000
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-109000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1000000	usd
CY2024Q1	crex	Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium	839000	usd
CY2023Q1	crex	Depreciation Depletion And Amortization Excluding Amortization Of Debt Discount Premium DepreciationDepletionAndAmortizationExcludingAmortizationOfDebtDiscountPremium	779000	usd
CY2024Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	360000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	356000	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	3000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	298000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	237000	usd
CY2024Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-604000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	76000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	24000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2952000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1177000	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	498000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-788000	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	172000	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1015000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-2976000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-486000	usd
CY2024Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	317000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-45000	usd
CY2024Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	645000	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2382000	usd
CY2024Q1	crex	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	1178000	usd
CY2023Q1	crex	Increase Decrease In Customer Deposit IncreaseDecreaseInCustomerDeposit	-1693000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	1000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	40000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1938000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	3868000	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	31000	usd
CY2024Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	824000	usd
CY2023Q1	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	1003000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-830000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1034000	usd
CY2024Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	10000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	2000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-1119000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-562000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-11000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2272000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2910000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1633000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2899000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3905000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	28831000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-109000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	28849000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	25579000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	139000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1000000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	25082000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	66666666
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-53455000	usd
CY2024Q1	crex	Working Capital WorkingCapital	22418000	usd
CY2024Q1	us-gaap	Debt Current DebtCurrent	12770000	usd
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2899000	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-76000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1938000	usd
CY2024Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	2384000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2063000	usd
CY2024Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	681000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	701000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	984000	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	237000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	-0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	4000	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	701000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1217000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	504000	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	3065000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	2567000	usd
CY2024Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6222800
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7339582
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	usd
CY2024Q1	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><i><em style="font: inherit;">10.</em> Use of Estimates</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting periods. Our significant estimates include: contingent purchase consideration valuation, allowance for credit losses, valuation allowances related to deferred taxes, the fair value of acquired assets and liabilities, the fair value of liabilities reliant upon the appraised fair value of the Company, valuation of stock-based compensation awards and other assumptions and estimates used to evaluate the recoverability of long-lived assets, goodwill and other intangible assets and the related amortization methods and periods. Actual results could differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q4	crex	Business Acquisition Extension Option Minimum Extension Threshold Price Increase In Price BusinessAcquisitionExtensionOptionMinimumExtensionThresholdPriceIncreaseInPrice	1
CY2024Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	12285000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	9944000	usd
CY2024Q1	crex	Capitalized Software In Accounts Payable CapitalizedSoftwareInAccountsPayable	89000	usd
CY2023Q1	crex	Capitalized Software In Accounts Payable CapitalizedSoftwareInAccountsPayable	369000	usd
CY2024Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	0	usd
CY2023Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	10000	usd
CY2024Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	9000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	40000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	323000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	287000	usd
CY2024Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	190000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	188000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	34177000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10192000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	33464000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9402000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	10192000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	9402000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	23985000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	24062000	usd
CY2024Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	790000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	754000	usd
CY2024Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	14038000	usd
CY2024Q1	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1731499
CY2024Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1268000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	12770000	usd
CY2024Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	12770000	usd
CY2024Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	0	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	15147000	usd
CY2023	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	1731499
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	1628000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	13519000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	3690000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	9829000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	9000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	43000	usd
CY2024Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	77000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	73000	usd
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	4587002
CY2024Q1	crex	Class Of Warrant Or Right Weighted Average Remaining Contractual Term ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm	P3Y10M9D
CY2023	crex	Class Of Warrant Or Right Weighted Average Remaining Contractual Term ClassOfWarrantOrRightWeightedAverageRemainingContractualTerm	P4Y1M9D
CY2024Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y10M2D

Files In Submission

Name	View Source	Status
0001437749-24-015814-index-headers.html	Edgar Link	pending
0001437749-24-015814-index.html	Edgar Link	pending
0001437749-24-015814.txt	Edgar Link	pending
0001437749-24-015814-xbrl.zip	Edgar Link	pending
crex-20240331.xsd	Edgar Link	pending
crex20240331_10q.htm	Edgar Link	pending
crexlogonew.jpg	Edgar Link	pending
ex_632214.htm	Edgar Link	pending
ex_632215.htm	Edgar Link	pending
ex_632216.htm	Edgar Link	pending
ex_632217.htm	Edgar Link	pending
ex_671394.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
crex-20240331_cal.xml	Edgar Link	unprocessable
crex-20240331_def.xml	Edgar Link	unprocessable
crex-20240331_lab.xml	Edgar Link	unprocessable
crex-20240331_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
crex20240331_10q_htm.xml	Edgar Link	completed
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CREX
CREATIVE REALITIES, INC. Stock $crex

2024 Q2 Form 10-Q Financial Statement

#000143774924015814 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CREX CREATIVE REALITIES, INC. Stock $crex

2024 Q2 Form 10-Q Financial Statement

#000143774924015814 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CREX
CREATIVE REALITIES, INC. Stock $crex